Analyst consensus rating
Pharvaris Analyst Rating: Strong Buy
Direct answer
Pharvaris's consensus rating is Strong Buy.
14 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $57.82.
Forecast evidence checked September 28, 2026.
Get free Pharvaris email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.91
- Average price target
- $57.82
- High price target
- $77.25
- Low price target
- $41.65
- Low target gap
- +30.5%
- Target upside
- +81.2%
- High target gap
- +142.1%
- Target range width
- 111.6%
- Consensus rating
- Strong Buy
- Analysts
- 14
- Evidence date
- September 28, 2026
- Valid through
- October 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Pharvaris?
Pharvaris has a verified Strong Buy consensus. The same dataset has an average price target of $57.82.
How far are Pharvaris's low and high targets from the recorded price?
The low target implies +30.5%, while the high target implies +142.1%.
How many analysts are included in Pharvaris's consensus?
The verified consensus includes 14 analysts.
How is Pharvaris's target upside or downside calculated?
The average target of $57.82 is divided by the recorded price of $31.91, then one is subtracted to produce +81.2%. This does not guarantee a future return.
When was Pharvaris's analyst forecast verified?
The data was verified on 2026-09-28. The dataset is valid through 2026-10-05.